Hemang Jani's top 2 long-term midcap recommendations

economictimes.indiatimes.com:

Market expert Hemang Jani says he «would go with some of the midcap cement companies. So, NCL is something which has done very well in the last one month or so. It is a smallcap, Rs 1,000-crore cement company and the numbers were exceptionally good and you do hear more and more M&A related transactions and that could re-rate the entire sector.

So, NCL can give a 25-30% kind of an upside. Apart from that, VIP Industries is another stock where we have seen a good amount of momentum and again M&A kind of a play. So, I think these are the stocks where in a subdued market you could see because of certain corporate actions which are likely to happen.»What about the US generic driven pharma companies as well that have put out fairly decent set of numbers? What has been your take on the quarterly performance?Quarterly performance has been by and large good, whether you look at Sun Pharma, Cipla or Dr Reddy's which gave standout performance and exceptionally good outlook also.

After a long pause, we are seeing that uptick and it looks like generic opportunity will remain pretty good from a medium to long term perspective. Dr Reddy's and Sun Pharma are the two names where one can really take a medium to long term kind of a view and play for 18-20% kind of an upside.What are your top 3 mid cap recommendations for the long term? I would go with some of the midcap cement companies. So, NCL is something which has done very well in the last one month or so.

It is a smallcap, Rs 1,000-crore cement company and the numbers were exceptionally good and you do hear more and more M&A related transactions and that could re-rate the entire sector. So, NCL can give a 25-30% kind of an upside. Apart from that, VIP Industries is another stock